_version_ 1784615575982440448
author Henriquez, Soledad
Zerbit, Jérémie
Bruel, Timothée
Ouedrani, Amani
Planas, Delphine
Deschamps, Paul
Staropoli, Isabelle
Hadjadj, Jérôme
Varet, Bruno
Ermak, Natalia
Bouscary, Didier
Willems, Lise
Fouquet, Guillemette
Decroocq, Justine
Franchi, Patricia
Deau-Fischer, Benedicte
Terrier, Benjamin
Tamburini, Jérôme
Chatenoud, Lucienne
Schwartz, Olivier
Vignon, Marguerite
author_facet Henriquez, Soledad
Zerbit, Jérémie
Bruel, Timothée
Ouedrani, Amani
Planas, Delphine
Deschamps, Paul
Staropoli, Isabelle
Hadjadj, Jérôme
Varet, Bruno
Ermak, Natalia
Bouscary, Didier
Willems, Lise
Fouquet, Guillemette
Decroocq, Justine
Franchi, Patricia
Deau-Fischer, Benedicte
Terrier, Benjamin
Tamburini, Jérôme
Chatenoud, Lucienne
Schwartz, Olivier
Vignon, Marguerite
author_sort Henriquez, Soledad
collection PubMed
description
format Online
Article
Text
id pubmed-8674107
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology.
record_format MEDLINE/PubMed
spelling pubmed-86741072021-12-16 Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma Henriquez, Soledad Zerbit, Jérémie Bruel, Timothée Ouedrani, Amani Planas, Delphine Deschamps, Paul Staropoli, Isabelle Hadjadj, Jérôme Varet, Bruno Ermak, Natalia Bouscary, Didier Willems, Lise Fouquet, Guillemette Decroocq, Justine Franchi, Patricia Deau-Fischer, Benedicte Terrier, Benjamin Tamburini, Jérôme Chatenoud, Lucienne Schwartz, Olivier Vignon, Marguerite Blood Letters to Blood American Society of Hematology. 2022-02-10 2021-12-16 /pmc/articles/PMC8674107/ /pubmed/34905598 http://dx.doi.org/10.1182/blood.2021013714 Text en Copyright © 2022 American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters to Blood
Henriquez, Soledad
Zerbit, Jérémie
Bruel, Timothée
Ouedrani, Amani
Planas, Delphine
Deschamps, Paul
Staropoli, Isabelle
Hadjadj, Jérôme
Varet, Bruno
Ermak, Natalia
Bouscary, Didier
Willems, Lise
Fouquet, Guillemette
Decroocq, Justine
Franchi, Patricia
Deau-Fischer, Benedicte
Terrier, Benjamin
Tamburini, Jérôme
Chatenoud, Lucienne
Schwartz, Olivier
Vignon, Marguerite
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
title Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
title_full Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
title_fullStr Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
title_full_unstemmed Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
title_short Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
title_sort anti-cd38 therapy impairs sars-cov-2 vaccine response against alpha and delta variants in patients with multiple myeloma
topic Letters to Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674107/
https://www.ncbi.nlm.nih.gov/pubmed/34905598
http://dx.doi.org/10.1182/blood.2021013714
work_keys_str_mv AT henriquezsoledad anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT zerbitjeremie anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT brueltimothee anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT ouedraniamani anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT planasdelphine anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT deschampspaul anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT staropoliisabelle anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT hadjadjjerome anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT varetbruno anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT ermaknatalia anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT bouscarydidier anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT willemslise anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT fouquetguillemette anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT decroocqjustine anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT franchipatricia anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT deaufischerbenedicte anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT terrierbenjamin anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT tamburinijerome anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT chatenoudlucienne anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT schwartzolivier anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma
AT vignonmarguerite anticd38therapyimpairssarscov2vaccineresponseagainstalphaanddeltavariantsinpatientswithmultiplemyeloma